Inside the White House with D.C.'s most wired reporter. Sign up for Mike Allen's Axios AM.

Stories

Gilead taps Roche pharma exec as new CEO

Gilead Sciences logo on a cell phone screen.
Gilead is known for making hepatitis C and HIV medicines. Photo: Igor Golovniov/SOPA Images/LightRocket via Getty Images

Gilead Sciences has named Daniel O'Day, the chief of Roche's pharmaceuticals unit, as its new CEO, effective March 1.

Why it matters: Gilead is one of the largest and most profitable drug manufacturers on the planet, known for its hepatitis C and HIV medicines. O'Day will lead a company that has had falling sales of its hepatitis drugs and is investing more in new, expensive gene therapies.

More stories loading.